Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Publication year range
1.
Hinyokika Kiyo ; 55(10): 611-3, 2009 Oct.
Article in Japanese | MEDLINE | ID: mdl-19926945

ABSTRACT

A 59-year-old man visited another hospital with a chief complaint of malaise. Radiological examinations revealed a renal cell carcinoma associated with horseshoe kidney. He was referred to our hospital. The patient was successfully treated with open partial nephrectomy following isthmus division. Histological findings exhibited grade 2, pT1a, clear cell type, renal cell carcinoma. He is free of disease at twelve months after the operation.


Subject(s)
Carcinoma, Renal Cell/complications , Kidney Neoplasms/complications , Kidney , Carcinoma, Renal Cell/surgery , Humans , Kidney/abnormalities , Kidney Neoplasms/surgery , Male , Middle Aged , Nephrectomy
2.
Hinyokika Kiyo ; 55(12): 765-8, 2009 Dec.
Article in Japanese | MEDLINE | ID: mdl-20048562

ABSTRACT

A 69-year-old female presented with hypertension and a solid mass in the bladder on ultrasonography. Cystoscopy revealed a submucosal tumor in the right lateral wall of the bladder. A transurethral resection was performed. Histologically, pathologic examination revealed a malignant pheochromocytoma. She refused surgical therapy and radiation therapy. She had no treatment for two years. She suddenly complained of gross hematuria. T2-weighted magnetic resonance imaging showed a bladder tumor of high intensity and extra-bladder invasion. She was treated with chemotherapy (CVD) for 26 cycles. Since the tumor size was reduced, she was referred to our hospital for operative indication. Partial cystectomy was performed. Histologically, the tumor was a pheochromocytoma of the urinary bladder. Ten months after the operation, she has no clinical evidence of recurrence.


Subject(s)
Pheochromocytoma/drug therapy , Urinary Bladder Neoplasms/drug therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/therapeutic use , Dacarbazine/therapeutic use , Female , Humans , Neoadjuvant Therapy , Pheochromocytoma/surgery , Urinary Bladder Neoplasms/surgery , Vincristine/therapeutic use
4.
Kansenshogaku Zasshi ; 80(3): 257-61, 2006 May.
Article in Japanese | MEDLINE | ID: mdl-16780133

ABSTRACT

A 75-year-old woman was admitted with fever of unknown origin and liver damage, and treated with prednisolone. Hypercalcemia appeared when of the dose of prednisolone was reduced, and human T-cell lymphotropic virus type-I (HTLV-I) proviral DNA was detected in the leukemic cells by Southern blot analysis, and a diagnosis of acute adult T-cell lymphoma (ATL) was made. After chemotherapy with sobuzoxane was started, she went into septic shock caused by multiple resistant Serratia marcesense, and was treated with PMX-DHP and antibiotics. Although ner general condition and her serum cytokine leyels improved, the septic shock became more severe, and the patient died. Serratia marcesense expreses lipopolysaccharide (LPS), a biologically active substance that is present in gram-negative bacteria. Exposure to LPS leads to activation of cytokines, including TNF-alpha, IL-1beta, IL-6, and IFN-gamma. After treatment with PMX-DHP, the patient's general condition improved, but she died of septic shock. Bacterial infection may be a life-threatening complication in the immunocompromised hosts and elderly patients, particularly when granulocytopenia has been induced by chemotherapy, and thus such these patients require careful management.


Subject(s)
Leukemia, T-Cell/complications , Serratia Infections/complications , Serratia marcescens , Shock, Septic/complications , Aged , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...